← Open Payments lookup

LETICIA PILAR: Open Payments

NPI 1437705852 · COPPELL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,358 in 115 payments from 27 companies in 2025. Trend: 2023 $739 · 2024 $2,151 · 2025 $2,358

Food & beverage: $2,259Education: $99
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$266
Novo Nordisk Inc12$237
AstraZeneca Pharmaceuticals LP9$227
Astellas Pharma US Inc6$211
ABBVIE INC.13$209
Lilly USA, LLC11$175
PFIZER INC.10$141
Boehringer Ingelheim Pharmaceuticals, Inc.5$107
Amgen Inc.5$83
Axsome Therapeutics, Inc.3$71

Products named: REXULTI, JARDIANCE, VRAYLAR, Veozah, FARXIGA, Ozempic, MOUNJARO, Wegovy.

Industry payments across TX — which companies pay providers there.